0.22
+0.0276(+14.52%)
Currency In USD
Address
2080 Century Park East
Los Angeles, CA 90067
United States of America
Phone
305 918 1980
Website
Sector
Healthcare
Industry
Biotechnology
Employees
29
First IPO Date
September 30, 2025
| Name | Title | Pay | Year Born |
| David H. Weinstein | Chief Executive Officer & Director | 421,894 | 1960 |
| Nathen Fuentes | Chief Financial Officer | 279,684 | 1983 |
| Greg Duczynski | Senior Vice President for Clinical Operations | 0 | N/A |
A company rebranding from Renovaro, focusing on AI-powered therapeutics and biodefense, with “Neurotoxicity Intelligence Technology” in development.
